Biotech

All Articles

Amgen reports initial stage 3 gain for $400M dermatitis medication

.Amgen has actually shared (PDF) the first phase 3 records on its own $400 thousand dermatitis medic...

Biogen, UCB file phase 3 lupus win after falling short earlier test

.Biogen and UCB's depend improving right into phase 3 astride a failed research aims to have repaid,...

Aptadir wishes new RNA preventions can easily turn around tricky cancers cells

.Italian biotech Aptadir Rehabs has released with the guarantee that its own pipe of preclinical RNA...

Wave surfs DMD excellence to regulators' doors, delivering stockpile

.Surge Lifestyle Sciences has fulfilled its own goal in a Duchenne muscle dystrophy (DMD) research s...

Sanofi tweezes new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma creas...

Achilles drips cell treatment course, bandages for unemployments after missing out on 'industrial feasibility' targets

.Achilles Therapeutics has torn up its own technique. The British biotech is actually knocking off o...

Aligos proclaims stage 2 MASH succeed, slashing liver excess fat as much as 46%

.Aligos Therapies is trumpeting a midstage gain in metabolic-dysfunction linked steatohepatitis (MAS...

Basilea credit ratings $268M BARDA funding for antifungals, antibiotics

.Basilea Pharmaceutica's job establishing brand-new antifungals has obtained a significant increase ...

Capricor offers Europe liberties to late-stage DMD treatment for $35M

.Having currently scooped up the united state rights to Capricor Therapeutics' late-stage Duchenne m...

FDA junks adcomm for Applied's rare disease medicine

.After pushing back the selection date for Applied Therapies' metabolic disorder medication govorest...